Incannex Healthcare
- Country
- 🇦🇺Australia
- Ownership
- -
- Employees
- 10
- Market Cap
- $34.7M
- Introduction
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on July 5, 2023 and is headquartered in Norwes...
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients with OSA
- Conditions
- Interventions
- First Posted Date
- 2023-11-24
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Incannex Healthcare Ltd
- Target Recruit Count
- 560
- Registration Number
- NCT06146101
- Locations
- 🇺🇸
Desert Center for Allergy and Chest Diseases, Pheonix, Arizona, United States
🇺🇸Exalt Clinical Research, Chula Vista, California, United States
🇺🇸CenExel CNS- Los Alamitos, Long Beach, California, United States
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2023-07-12
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- Incannex Healthcare Ltd
- Target Recruit Count
- 128
- Registration Number
- NCT05942911
- Locations
- 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺Emeritus Research, Sydney, New South Wales, Australia
🇦🇺Captain Sterling Medical Centre, Nedlands, Western Australia, Australia
Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
- Conditions
- Interventions
- First Posted Date
- 2023-05-12
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Incannex Healthcare Ltd
- Target Recruit Count
- 116
- Registration Number
- NCT05857384
- Locations
- 🇦🇺
CMAX, Adelaide, South Australia, Australia
🇦🇺Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
🇦🇺Nucleus Network Pty Ltd [Commercial Road], Melbourne, Victoria, Australia